Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
December 17, 2019
Bictegravir, a novel integrase inhibitor for the treatment of HIV infection
J Zeuli, S Rizza, R Bhatia, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
February 12, 2019
Ibalizumab for the treatment of multidrug-resistant HIV-1 infection
S A Rizza, R Bhatia, J Zeuli, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
December 8, 2011
Telaprevir: looking for a sustained virologic response in hepatitis C virus infection
V Nehra, S A Rizza, R Talwani, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
November 15, 2011
Boceprevir
S A Rizza, R Talwani, V Nehra, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
April 20, 2016
Ledipasvir/sofosbuvir fixed-dose combination for treatment of hepatitis C virus genotype 4 infection
V Nehra, E M Tan, S A Rizza, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
February 14, 2014
Simeprevir: a macrocyclic HCV protease inhibitor
R Talwani, E L Heil, B L Gilliam, et al.
Mayo Clinic Proceedings
|
September 3, 1999
Central nervous system histoplasmosis mimicking a brain tumor: difficulties in diagnosis and treatment
C J Klein, R P Dinapoli, Z Temesgen, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
January 9, 2016
Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection
J D Zeuli, S K Adie, S A Rizza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 24, 1998
Acute pancreatitis associated with Cryptosporidium parvum enteritis in an immunocompetent man
S M Norby, A E Bharucha, M V Larson, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
March 31, 2012
Current status of treatment for chronic hepatitis C virus infection
R Talwani, B L Gilliam, S A Rizza, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Drugs of Today (Barcelona, Spain : 1998)
|
December 17, 2019
Bictegravir, a novel integrase inhibitor for the treatment of HIV infection
J Zeuli, S Rizza, R Bhatia, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
February 12, 2019
Ibalizumab for the treatment of multidrug-resistant HIV-1 infection
S A Rizza, R Bhatia, J Zeuli, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
December 8, 2011
Telaprevir: looking for a sustained virologic response in hepatitis C virus infection
V Nehra, S A Rizza, R Talwani, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
November 15, 2011
Boceprevir
S A Rizza, R Talwani, V Nehra, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
April 20, 2016
Ledipasvir/sofosbuvir fixed-dose combination for treatment of hepatitis C virus genotype 4 infection
V Nehra, E M Tan, S A Rizza, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
February 14, 2014
Simeprevir: a macrocyclic HCV protease inhibitor
R Talwani, E L Heil, B L Gilliam, et al.
Mayo Clinic Proceedings
|
September 3, 1999
Central nervous system histoplasmosis mimicking a brain tumor: difficulties in diagnosis and treatment
C J Klein, R P Dinapoli, Z Temesgen, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
January 9, 2016
Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection
J D Zeuli, S K Adie, S A Rizza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 24, 1998
Acute pancreatitis associated with Cryptosporidium parvum enteritis in an immunocompetent man
S M Norby, A E Bharucha, M V Larson, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
March 31, 2012
Current status of treatment for chronic hepatitis C virus infection
R Talwani, B L Gilliam, S A Rizza, et al.
Page
of 4